Natus Medical Inc. announced unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2009. For the fourth quarter ended December 31, 2009, the company reported revenue of $51.6 million, compared to $43.4 million reported in the comparable quarter of the previous year. Net income was $4.3 million, or $0.15 per diluted share, for the fourth quarter of 2009, compared with net income of $6.3 million, or $0.22 per diluted share, for the fourth quarter of 2008. The company reported income from operations of $5.12 million and income before provision for income tax of $6.29 million compared to income from operations of $8.45 million and income before provision for income tax of $9.64 million for the same period last year. The company reported non-GAAP net income of $4.26 million or $0.15 diluted per share compared to $6.29 million or $0.22 diluted per share for the same period last year. For the year ended December 31, 2009, the company reported revenue of $166.5 million, compared to $161.8 million reported in 2008. Net income was $11.1 million, or $0.39 per diluted share for the year ended December 31 2009, compared to net income of $17.5 million, or $0.66 per diluted share in 2008. Excluding the direct costs, which were reported as a component of general and administrative expense, non-GAAP earnings were $11.5 million or $0.40 per diluted share compared to non-GAAP net income of $17.47 million or $0.66 diluted per share for the same period last year. The company reported income from operations of $14.82 million and income before provision for income tax of $16.57 million compared to income from operations of $25.48 million and income before provision for income tax of $27.63 million for the same period last year. The company announced on January 13, 2010, it communicated its financial guidance for the full year ending December 31, 2010, where it expected revenue to be approximately $198 million and earnings per share to range from $0.45 to $0.47. The company's guidance gave effect to a restructuring charge that the company will record in the first quarter of 2010 that is expected to reduce earnings per share by approximately $0.05. On a non-GAAP basis the company expects earnings per share to range from $0.60 to $0.62 for the full year 2010. The company expects that excluding the effect of these charges from net income will result in an increase to earnings per share of $0.15 for the full year 2010. For the first quarter ending March 31, 2010, the company expects revenue to range from $46 million to $47 million and earnings per share to range from a loss of $0.01 to breakeven. This guidance gives effect to the aforementioned restructuring charge that will reduce first quarter earnings per share by $0.05. The company's first quarter 2010 guidance compares to revenue of $33.4 million and earnings per share of $0.03 reported in the first quarter of 2009. On a non-GAAP basis the company expects earnings per share to range from $0.06 to $0.07 for the first quarter of 2010. The company expects that excluding the effect of these charges from net income will result in an increase to earnings per share of $0.07 for the first quarter of 2010.

Natus Medical Inc. expected to Report Q1 2010 Results on April 26, 2010. This event was calculated by Capital IQ (Created on March 4, 2010).

Natus Medical Incorporated announced financial results for the fourth quarter and full year ended December 31, 2009. The company reported revenue of $51.6 million for the fourth quarter. The company intends to look at acquisition opportunities. Jim Hawkins, President and Chief Executive Officer of the Company said: "We are looking to do additional acquisitions in the second half of 2010 as we continue to execute our business model of combining internal growth and accretive acquisitions."

Natus to Present at the Roth Capital Partners 22nd Annual Growth Stock Conference

NATUS MEDICAL INC Files SEC form 10-K, Annual Report

Natus to Present at the Roth Capital Partners 22nd Annual Growth Stock Conference

NATUS MEDICAL INC Files SEC form 8-K, Change in Directors or Principal Officers

[$$] 13D Filings

Natus Executives to Present at Upcoming Financial Conferences

Natus Medical to Hold 2009 Fourth Quarter Financial Results Conference Call on March 4

Natus Medical Announces 2009 Fourth Quarter and Full Year Financial Results

Natus Medical Announces 2009 Fourth Quarter and Full Year Financial Results

UPDATE - Natus Medical Q4 profit meets Street

Q4 2009 Natus Medical Incorporated Earnings Release - Before Market Open

NATUS MEDICAL INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exhibit

Natus Medical Incorporated Earnings Call scheduled for 11:00 am ET today

Natus will restructure sales force, close plant

Natus Executives to Present at Upcoming Financial Conferences

Natus Medical to Hold 2009 Fourth Quarter Financial Results Conference Call on March 4

Natus Medical Announces Reorganization

Natus will restructure sales force, close plant

Natus Medical Announces Reorganization

UPDATE - Natus Medical to cut 50 jobs, cuts '10 EPS view